Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information on how we use and manage cookies please take a look at our privacy and cookie policies. Some parts of the site may not work properly if you choose not to accept cookies.

sections
Home > KPMG > Independence, in name and fact: Global Pharmaceutical Manufacturer
 

Independence, in name and fact: Global Pharmaceutical Manufacturer

White Paper Published By: KPMG
KPMG
Published:  Sep 17, 2018
Type:  White Paper
Length:  1 pages

The leadership of a new, marquee pharma manufacturer approached KPMG with a paradox: It was certainly marquee, but not new. As the highly publicized spin-off of a global health services conglomerate, the company began life with $18 billion in annual revenues, an established product pipeline and instant membership in the S&P 100. Reliant on the back office functions of its parent, it needed to quickly acquire the back office sinews of a truly stand-alone company: ERP systems and core processes for finance, operations and human resources. 

During an intensive three-year engagement, KPMG brought the vision of the company’s leaders to life, working towards a target operating model through the disciplined implementation of new systems, processes, training and staffing. The multidisciplinary approach eventually touched the lives of every one of the company’s 21,000 employees, in 170 countries. And as KPMG’s delivered tangible results, something intangible emerged – a new company culture, independent in name, spirit and operational fact.

We know how to get things done.



Tags :